Coulter:Partners
 Small-cap Placement News Bulletin
 Q3 2018
 

Highlights

 
This quarter’s successful placements include:
  • President & CEO for a US corporate VC-backed drug developer of therapies intended to provide treatment of neurologic and oncologic diseases
  • CEO for a German next generation vaccines developer, backed by several leading VCs in the DACH region
  • Two Chief Scientific Officers for VC-funded biotechs in oncology and immunology
  • VP Marketing & Market Access for a Swiss developer of a implantable neuro-stimulation system; backed by several European VC and private equity funds
  • Chief Medical Officer for a US musculoskeletal products developer that has raised over $210m to date
Newly opened assignments include:
  • President & CEO for a US corporate VC-backed drug developer of therapies intended to provide treatment of neurologic and oncologic diseases
  • CEO for a German next generation vaccines developer, backed by several leading VCs in the DACH region
  • Xxx xxx
  • Xxx xxx
  • Xxx xxx

Themes

 
Areas of focus include but are not limited to:
  • Oncology
  • Neurology
  • Immunology
  • Genomics
  • Vaccines
  • Medical Devices

Coulter Partners

  • Global market leader and largest global executive search firm dedicated to the Life Sciences and committed to delivering outstanding leadership
  • 80+ sector experts from a diversity of backgrounds working across 10 global offices.
  • Unrivalled network with the Life Sciences community with 250+ assignments each year across all segments of the industry.
  • Deep understanding of talent needs, business models, sector trends, scientific evolution, innovation and competitive positioning
  • Large proportion of search work for VC, PE and angel-funded biotech, medtech, and digital health companies
  • Working with 50+ VC and PE funds across US, UK and EMEA
  • 400+ senior leadership assignments for investor portfolio companies